Financials and Filings FINANCIALS AND FILINGS submenu Overview SEC Filings Annuals & Proxies Quarterly Results Key Ratios Show all 2022 Fourth Quarter Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update Form 10-Q Filing date View May 04, 2023 View HTML 0001628280-23-015458.pdf 0001628280-23-015458.rtf 0001628280-23-015458.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA November 03, 2022 View HTML 0001193125-22-276406.pdf 0001193125-22-276406.rtf 0001193125-22-276406.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-K Filing date View March 01, 2023 View HTML 0001193125-23-055176.pdf 0001193125-23-055176.rtf 0001193125-23-055176.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA March 01, 2022 View HTML 0001193125-22-059849.pdf 0001193125-22-059849.rtf 0001193125-22-059849.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Proxy Statements Filing date View April 28, 2023 View HTML 0001193125-23-127257.pdf 0001193125-23-127257.xls 0001193125-23-127257.rtf EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA April 21, 2022 View HTML 0001193125-22-113145.pdf 0001193125-22-113145.xls 0001193125-22-113145.rtf
